South & Central America Poultry Vaccines Market Forecast to 2031 - Regional Analysis - by Type (Broiler and Layer), Technology (Live Attenuated Vaccines, Inactivated Vaccines, and Recombinant Vaccines), Dosage Form (Liquid Vaccines, Freeze-Dried Vaccines, and Dust/Powdered Vaccines), Disease (Avian Influenza, Salmonellosis, Mareks Disease, Infectious Bronchitis (IB), Infectious Bursal Disease (IBD), Newcastle Disease, and Others), Route Of Administration (Drinking water (D/W), Intramuscular (I/M), Subcutaneous (S/C), and Others), and End User (Poultry Farms, Veterinary Hospitals, and Poultry Vaccination Centers and Clinics)

TIPRE00023752 | Pages: 111 | Pharmaceuticals | Oct 2024 | Type: Regional | Status: Published

The South & Central America poultry vaccines market was valued at US$ 298.35 million in 2023 and is expected to reach US$ 551.23 million by 2031; it is estimated to record a CAGR of 8.0% from 2023 to 2031.

Government Support for Mass Vaccination Drives and Innovative Schemes Fuel South & Central America Poultry Vaccines Market

Government worldwide is supportive against poultry vaccination with rising Global Burden of Disease (GBD). The support involves launching of mass vaccination schemes and several vaccination programs at vaccination centers or through door-step immunization services.

  • In 2024, in an effort to stop the spread of avian influenza, the Peruvian Poultry Association (APA) and the National Agrarian Health Service (Senasa) of Peru have implemented new rules. Directorial Resolution No. 0014-2024-Midagri-Senasa-DSA contains the regulations that require vaccination for specific poultry farms and health certification for the transportation of birds and products. A registered poultry health practitioner must supervise the immunization procedure. Senasa and the poultry industry are working together to improve the national poultry industry and guarantee the health of Peru's chicken population. This program is a part of that effort.

Therefore, such government support for mass vaccination drives and designing innovative schemes is anticipated to provide lucrative opportunities for the poultry market growth in the coming years.

South & Central America Poultry Vaccines Market Overview

The South & Central America poultry vaccines market is segmented into Argentina, Brazil, and the Rest of South & Central America. Brazil is expected to hold the major market share in this region. The poultry vaccines market in this region is expected to grow rapidly due to expanding healthcare facilities, rising demand for protein-rich foods, and initiatives taken by various government agencies and animal associations.

South & Central America Poultry Vaccines Market Revenue and Forecast to 2031 (US$ Million)

South & Central America Poultry Vaccines Market Revenue and Forecast to 2031 (US$ Million)

Get more information on this report :

South & Central America Poultry Vaccines Market Segmentation

The South & Central America poultry vaccines market is categorized into type, technology, dosage form, disease, route of administration, end user, and country. 

Based on type, the South & Central America poultry vaccines market is bifurcated into broiler and layer. The broiler segment held a larger market share in 2023.

In terms of technology, the South & Central America poultry vaccines market is categorized into live attenuated vaccines, inactivated vaccines, and recombinant vaccines. The live attenuated vaccines segment held the largest market share in 2023.

By dosage form, the South & Central America poultry vaccines market is segmented into liquid vaccines, freeze-dried vaccines, and dust/powdered form vaccines. The liquid vaccines segment held the largest market share in 2023.

Based on disease, the South & Central America poultry vaccines market is categorized into avian influenza, infectious bronchitis, Marek's disease, avian salmonellosis, infectious bursal disease (IBD), Newcastle disease, and others. The Newcastle disease segment held the largest market share in 2023.

In terms of route of administration, the South & Central America poultry vaccines market is segmented into drinking water (D/W), intramuscular (I/M), subcutaneous (I/S), and others. The drinking water (D/W) segment held the largest market share in 2023.

Based on end user, the South & Central America poultry vaccines market is segmented into poultry farms & hatchery, veterinary hospitals, and poultry vaccination enters & clinics. The poultry farms & hatchery segment held the largest market share in 2023.

By country, the South & Central America poultry vaccines market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America poultry vaccines market share in 2023.

Boehringer Ingelheim International GmbH, Zoetis Inc, Phibro Animal Health Corp, Dechra Pharmaceuticals PLC, Elanco Animal Health Inc, Merck KGaA, Ceva, and Vaccinova AB. are some of the leading companies operating in the South & Central America poultry vaccines market.

TABLE OF CONTENTS

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

4. Poultry Vaccines Market - Key Market Dynamics

4.1 Market Drivers

4.1.1 Rising Prevalence of Poultry Diseases

4.1.2 Growing Poultry Industry

4.2 Market Restraints

4.2.1 Vaccination Failure and Improper Handling

4.3 Market Opportunities

4.3.1 Government Support for Mass Vaccination Drives and Innovative Schemes

4.4 Future Trends

4.4.1 Advancements in Vectored and Combination Vaccines

4.5 Impact of Drivers and Restraints:

5. South & Central America Poultry Vaccines Market Analysis

5.1 Poultry Vaccines Market Revenue (US$ Million), 2021-2031

6. South & Central America Poultry Vaccines Market Analysis - by Type

6.1 Overview

6.2 Broiler

6.2.1 Overview

6.2.2 Broiler: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

6.3 Layer

6.3.1 Overview

6.3.2 Layer: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

7. South & Central America Poultry Vaccines Market Analysis - by Technology

7.1 Overview

7.2 Live Attenuated Vaccines

7.2.1 Overview

7.2.2 Live Attenuated Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

7.3 Inactivated Vaccines

7.3.1 Overview

7.3.2 Inactivated Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

7.4 Recombinant Vaccines

7.4.1 Overview

7.4.2 Recombinant Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

8. South & Central America Poultry Vaccines Market Analysis - by Dosage Form

8.1 Overview

8.2 Liquid Vaccines

8.2.1 Overview

8.2.2 Liquid Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

8.3 Freeze-Dried Vaccines

8.3.1 Overview

8.3.2 Freeze-Dried Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

8.4 Dust/Powdered Vaccines

8.4.1 Overview

8.4.2 Dust/Powdered Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

9. South & Central America Poultry Vaccines Market Analysis - by Disease

9.1 Overview

9.2 Avian Influenza

9.2.1 Overview

9.2.2 Avian Influenza: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

9.3 Avian Salmonellosis

9.3.1 Overview

9.3.2 Avian Salmonellosis: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

9.4 Mareks Disease

9.4.1 Overview

9.4.2 Mareks Disease: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

9.5 Infectious Bronchitis (IB)

9.5.1 Overview

9.5.2 Infectious Bronchitis (IB): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

9.6 Infectious Bursal Disease (IBD)

9.6.1 Overview

9.6.2 Infectious Bursal Disease (IBD): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

9.7 Newcastle Disease

9.7.1 Overview

9.7.2 Newcastle Disease: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

9.8 Others

9.8.1 Overview

9.8.2 Others: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

10. South & Central America Poultry Vaccines Market Analysis - by Route of Administration

10.1 Overview

10.2 Drinking Water (D/W)

10.2.1 Overview

10.2.2 Drinking Water (D/W): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

10.3 Intramuscular (I/M)

10.3.1 Overview

10.3.2 Intramuscular (I/M): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

10.4 Subcutaneous (S/C)

10.4.1 Overview

10.4.2 Subcutaneous (S/C): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

10.5 Others

10.5.1 Overview

10.5.2 Others: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

11. South & Central America Poultry Vaccines Market Analysis - by End User

11.1 Overview

11.2 Poultry Farms

11.2.1 Overview

11.2.2 Poultry Farms: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

11.3 Veterinary Hospitals

11.3.1 Overview

11.3.2 Veterinary Hospitals: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

11.4 Poultry Vaccination Centers & Clinics

11.4.1 Overview

11.4.2 Poultry Vaccination Centers & Clinics: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

12. South & Central America Poultry Vaccines Market - Country Analysis

12.1 South & Central America Market Overview

12.1.1 Poultry Vaccines Market Breakdown by Countries

12.1.2 Poultry Vaccines Market Revenue and Forecast and Analysis - by Country

12.1.2.1 Brazil: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

12.1.2.1.1 Overview

12.1.2.1.2 Brazil: Poultry Vaccines Market Breakdown by Type

12.1.2.1.3 Brazil: Poultry Vaccines Market Breakdown by Technology

12.1.2.1.4 Brazil: Poultry Vaccines Market Breakdown by Dosage Form

12.1.2.1.5 Brazil: Poultry Vaccines Market Breakdown by Disease

12.1.2.1.6 Brazil: Poultry Vaccines Market Breakdown by Route of Administration

12.1.2.1.7 Brazil: Poultry Vaccines Market Breakdown by End User

12.1.2.2 Argentina: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

12.1.2.2.1 Overview

12.1.2.2.2 Argentina: Poultry Vaccines Market Breakdown by Type

12.1.2.2.3 Argentina: Poultry Vaccines Market Breakdown by Technology

12.1.2.2.4 Argentina: Poultry Vaccines Market Breakdown by Dosage Form

12.1.2.2.5 Argentina: Poultry Vaccines Market Breakdown by Disease

12.1.2.2.6 Argentina: Poultry Vaccines Market Breakdown by Route of Administration

12.1.2.2.7 Argentina: Poultry Vaccines Market Breakdown by End User

12.1.2.3 Rest of South & Central America: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

12.1.2.3.1 Overview

12.1.2.3.2 Rest of South & Central America: Poultry Vaccines Market Breakdown by Type

12.1.2.3.3 Rest of South & Central America: Poultry Vaccines Market Breakdown by Technology

12.1.2.3.4 Rest of South & Central America: Poultry Vaccines Market Breakdown by Dosage Form

12.1.2.3.5 Rest of South & Central America: Poultry Vaccines Market Breakdown by Disease

12.1.2.3.6 Rest of South & Central America: Poultry Vaccines Market Breakdown by Route of Administration

12.1.2.3.7 Rest of South & Central America: Poultry Vaccines Market Breakdown by End User

13. Industry Landscape

13.1 Overview

13.2 Growth Strategies in the Global Poultry Vaccines Market

13.3 Organic Developments

13.3.1 Overview

13.1 Inorganic Developments

13.1.1 Overview

14. Company Profiles

14.1 Boehringer Ingelheim International GmbH

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Zoetis Inc

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Phibro Animal Health Corp

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Dechra Pharmaceuticals PLC

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Elanco Animal Health Inc

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Merck KGaA

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 Ceva

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 Vaccinova AB

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

 

 

List of Tables

Table 1. South & Central America Poultry Vaccines Market Segmentation

Table 2. Brazil: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type

Table 3. Brazil: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology

Table 4. Brazil: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form

Table 5. Brazil: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease

Table 6. Brazil: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route of Administration

Table 7. Brazil: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 8. Argentina: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type

Table 9. Argentina: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology

Table 10. Argentina: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form

Table 11. Argentina: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease

Table 12. Argentina: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route of Administration

Table 13. Argentina: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 14. Rest of South & Central America: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type

Table 15. Rest of South & Central America: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology

Table 16. Rest of South & Central America: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form

Table 17. Rest of South & Central America: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease

Table 18. Rest of South & Central America: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route of Administration

Table 19. Rest of South & Central America: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 20. Organic Developments Done by Companies

Table 21. Inorganic Developments Done by Companies

Table 22. Glossary of Terms, Poultry Vaccines Market

 

List of Figures

Figure 1. South & Central America Poultry Vaccines Market Segmentation, by Country

Figure 2. Poultry Vaccines Market - Key Market Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Poultry Vaccines Market Revenue (US$ Million), 2021-2031

Figure 5. Poultry Vaccines Market Share (%) - by Type, 2023 and 2031

Figure 6. Broiler: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)

Figure 7. Layer: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)

Figure 8. Poultry Vaccines Market Share (%) - by Technology, 2023 and 2031

Figure 9. Live Attenuated Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)

Figure 10. Inactivated Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)

Figure 11. Recombinant Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)

Figure 12. Poultry Vaccines Market Share (%) - by Dosage Form, 2023 and 2031

Figure 13. Liquid Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)

Figure 14. Freeze-Dried Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)

Figure 15. Dust/Powdered Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)

Figure 16. Poultry Vaccines Market Share (%) - by Disease, 2023 and 2031

Figure 17. Avian Influenza: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)

Figure 18. Avian Salmonellosis: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)

Figure 19. Mareks Disease: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)

Figure 20. Infectious Bronchitis (IB): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)

Figure 21. Infectious Bursal Disease (IBD): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)

Figure 22. Newcastle Disease: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)

Figure 23. Others: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)

Figure 24. Poultry Vaccines Market Share (%) - by Route of Administration, 2023 and 2031

Figure 25. Drinking Water (D/W): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)

Figure 26. Intramuscular (I/M): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)

Figure 27. Subcutaneous (S/C): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)

Figure 28. Others: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)

Figure 29. Poultry Vaccines Market Share (%) - by End User, 2023 and 2031

Figure 30. Poultry Farms: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)

Figure 31. Veterinary Hospitals: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)

Figure 32. Poultry Vaccination Centers & Clinics: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)

Figure 33. South & Central America: Poultry Vaccines Market by Key Countries - Revenue 2023 (US$ Million)

Figure 34. Poultry Vaccines Market Breakdown by Key Countries, 2023 and 2031 (%)

Figure 35. Brazil: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

Figure 36. Argentina: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

Figure 37. Rest of South & Central America: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

Figure 38. Growth Strategies in the Poultry Vaccines Market

  1. Boehringer Ingelheim International GmbH.
  2. Zoetis Inc.
  3. Phibro Animal Health Corp.
  4. Dechra Pharmaceuticals PLC.
  5. Elanco Animal Health Inc.
  6. Merck KGaA.
  7. Ceva.
  8. Vaccinova AB.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America poultry vaccines market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the South & Central America poultry vaccines market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America poultry vaccines market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440